OXIOSCR has produced a group of network-orientated, highly trained and motivated researchers, and a platform for the synthesis of a new generation of anti-cancer molecules inspired by natural products.
Of all the new chemical entities approved for oncology to date, more than half are natural products or related molecules. New natural products and their derivatives have potential but their development to the clinic is often limited by poor bioavailability, toxicity and an inability to access sufficient quantities of material.
Further details: From thesis to synthesis: Potential anti-cancer compounds from natural products